Collectively, our findings indicate that TF may relieve the immunosuppressive effect on T cells by reducing the levels of PD‐L1 in cancer cells, thereby increasing the infiltration of T cells into the tumor tissue. The gene discussed is CD274; the disease is neoplasm.